Overview
Pirouette Pharma is a clinical-stage pharmaceutical company developing its own portfolio of injectable medications while partnering with biopharmaceutical companies to integrate their proprietary active pharmaceutical ingredients (APIs) into our next-generation delivery platform.
At the core of our technology is OnePush, a patented, disc‑shaped, push‑button auto‑injector featuring a fully automatic, hidden needle and smooth, controlled insertion. The device is specifically engineered to reduce needle sensation and overcome patient hesitation during home use.
As an API‑agnostic and partner‑ready platform, OnePush enables Pirouette’s dual-track growth strategy. We are advancing our own clinical programs to market while simultaneously executing co‑development agreements to house partner injectables for chronic conditions—such as oncology therapies, HIV medications, GLP-1s, and immunology biologics. By transforming the self-administration experience, Pirouette enhances therapy compliance and persistency, providing partner brands with a device-led, patient- and physician-preferred commercial advantage in highly competitive markets.